Search All UT System Experts

Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' Collaboration

Alex Pitcher, Jonathan Emberson, Ronald V. Lacro, Lynn A. Sleeper, Mario Stylianou, Lynn Mahony, Gail D. Pearson, Maarten Groenink, Barbara J. Mulder, Aeilko H. Zwinderman, Julie De Backer, Anne M. De Paepe, Eloisa Arbustini, Guliz Erdem, Xu Yu Jin, Marcus D. Flather, Michael J. Mullen, Anne H. Child, Alberto Forteza, Arturo EvangelistaHsin Hui Chiu, Mei Hwan Wu, George Sandor, Ami B. Bhatt, Mark A. Creager, Richard B. Devereux, Bart Loeys, J. Colin Forfar, Stefan Neubauer, Hugh Watkins, Catherine Boileau, Guillaume Jondeau, Harry C. Dietz, Colin Baigent

Research output: Contribution to journal › Article › peer-review

42 Scopus citations

Fingerprint

Dive into the research topics of 'Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' Collaboration'. Together they form a unique fingerprint.

Medicine & Life Sciences